KLK3 and prostate cancer: We have used both subcutaneous cell-derived xenograft models (DU-145 and PC3 prostate cancer cells engrafted in NSG mice) [181] and AR-positive/PSA-expressing prostate cancer PDX model (TM00298 PDX tumors engrafted in NSG mice) as in vivo models [184].